ELISIGEN
LIVE

Serial Number

99757544

Owner

ELISIGEN INC.

Attorney

KEITH R. OBERT

Filing Date

Apr 10, 2026

Add to watchlist:

No watchlists yet
View on USPTO

ELISIGEN Trademark

Serial Number: 99757544

ELISIGEN is a trademark filed by ELISIGEN INC. on April 10, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

ELISIGEN INC. (2 trademarks)

402-2, Sanhakgwan, 145 Anam-ro
Seoul 02841 , KR

Entity Type: 99

Trademark Details

Filing Date

April 10, 2026

Registration Date

Not Registered

Goods & Services

Wholesale distributorships featuring pharmaceutical preparations for the treatment of sensory organ disorders; Wholesale distributorships featuring pharmaceutical preparations for the treatment of peripheral nervous system disorders; Wholesale distributorships featuring pharmaceutical preparations for the treatment of central nervous system disorders; Wholesale distributorships featuring analgesics; Wholesale distributorships featuring immunomodulators; Wholesale distributorships featuring vaccines; Wholesale distributorships featuring chemical preparations for use in the manufacture of pharmaceuticals; Wholesale distributorships featuring biological preparations for medical and veterinary purposes; Wholesale distributorships featuring pharmaceutical preparations for the treatment of allergies; Wholesale distributorships featuring cosmetics

Nucleic acid sequences for medical and veterinary purposes; Synthetic peptides for pharmaceutical purposes; Cells for medical purposes; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of sensory organ disorders; Pharmaceutical preparations for the treatment of peripheral nervous system disorders; Pharmaceutical preparations for the treatment of tinnitus; Pharmaceutical preparations for the treatment of central nervous system disorders; Pain relief medication; Analgesics; Vaccines; Tranquilizers; Diagnostic preparations for medical purposes; Drug delivery agents in the form of coatings for tablets that facilitate the delivery of pharmaceutical preparations; Pharmaceutical preparations for the treatment of allergies

Scientific research in the field of pharmacogenetics; Research and development in the field of gene-based pharmaceuticals; Research and development services in the field of gene expression systems; Gene therapy research; Research in the field of gene editing technology; Scientific research in the field of genetics; Genetic testing for scientific research purposes; Pharmaceutical research services; Research and development services in the field of cosmetics; Food research

Filing History

APPLICATION FILING RECEIPT MAILED
Apr 10, 2026 MAFR
NEW APPLICATION ENTERED
Apr 10, 2026 NWAP